Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
作者信息
Abgral Ronan, Dweck Marc R, Trivieri Maria Giovanna, Robson Philip M, Karakatsanis Nicolas, Mani Venkatesh, Padilla Maria, Miller Marc, Lala Anuradha, Sanz Javier, Narula Jagat, Fuster Valentin, Contreras Johanna, Kovacic Jason C, Fayad Zahi A
机构信息
Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Nuclear Medicine, European University of Brittany, EA3878 GETBO, CHRU Brest, Brest, France.
Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
出版信息
JACC Cardiovasc Imaging. 2017 May;10(5):594-597. doi: 10.1016/j.jcmg.2016.02.029. Epub 2016 Jun 29.
Abstract
摘要
相似文献
1
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.联合FDG-PET/MR评估心肌疾病的临床应用价值
JACC Cardiovasc Imaging. 2017 May;10(5):594-597. doi: 10.1016/j.jcmg.2016.02.029. Epub 2016 Jun 29.
2
Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.杂交磁共振成像和正电子发射断层扫描与氟脱氧葡萄糖诊断活动性心脏结节病。
JACC Cardiovasc Imaging. 2018 Jan;11(1):94-107. doi: 10.1016/j.jcmg.2017.02.021. Epub 2017 Jun 14.
3
Prognostic Value of Combined Assessments of Late Gadolinium Enhancement and Fluorodeoxyglucose Uptake in Cardiac Sarcoidosis.钆增强晚期成像与氟脱氧葡萄糖摄取联合评估在心脏结节病中的预后价值
JACC Cardiovasc Imaging. 2024 Jun;17(6):710-712. doi: 10.1016/j.jcmg.2024.01.010. Epub 2024 Mar 20.
4
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.心脏磁共振成像/氟脱氧葡萄糖正电子发射断层显像联合检查用于鉴别活动性与慢性心脏结节病
JACC Cardiovasc Imaging. 2022 Mar;15(3):445-456. doi: 10.1016/j.jcmg.2021.08.018. Epub 2021 Oct 13.
5
Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.与氟代脱氧葡萄糖/灌注正电子发射断层扫描相比，用氟代胸苷正电子发射断层扫描成像诊断心脏结节病：一项前瞻性初步研究。
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2280-2281. doi: 10.1016/j.jcmg.2019.06.020. Epub 2019 Aug 14.
6
Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.使用混合心脏正电子发射断层扫描-磁共振成像技术对再灌注ST段抬高型心肌梗死患者的危险区域进行定量分析。
Circ Cardiovasc Imaging. 2016 Mar;9(3):e003900. doi: 10.1161/CIRCIMAGING.115.003900.
7
Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.杂交磁共振正电子发射断层扫描与心脏结节病的心脏相关结局相关。
JACC Cardiovasc Imaging. 2024 Apr;17(4):411-424. doi: 10.1016/j.jcmg.2023.11.010. Epub 2024 Jan 31.
8
Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.心脏结节病：18F-FDG PET与MRI的互补作用
J Cardiovasc Med (Hagerstown). 2020 Apr;21(4):335-336. doi: 10.2459/JCM.0000000000000919.
9
Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.冠状动脉 PET/MR 成像：可行性、局限性及解决方案。
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1103-1112. doi: 10.1016/j.jcmg.2016.09.029. Epub 2017 Jan 18.
10
Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.18F-FDG PET/MRI 联合应用于心脏结节病和心肌炎评估的初步经验。
Clin Nucl Med. 2017 Jul;42(7):e328-e334. doi: 10.1097/RLU.0000000000001669.
引用本文的文献
1
Hybrid PET/MRI in Inflammatory Cardiac Diseases: A Systematic Review and Single-Center Experience.炎症性心脏病中的PET/MRI混合成像：系统评价与单中心经验
Diagnostics (Basel). 2025 Jun 30;15(13):1670. doi: 10.3390/diagnostics15131670.
2
Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC.混合心血管成像。欧洲核医学协会（EANM）和欧洲心脏病学会（ESC）的欧洲心血管成像协会（EACVI）的临床共识声明。
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1095-1118. doi: 10.1007/s00259-024-06946-w. Epub 2024 Oct 22.
3
Recent advances in PET-MRI for cardiac sarcoidosis.PET-MRI在心脏结节病诊断中的最新进展。
Front Nucl Med. 2022 Dec 19;2:1032444. doi: 10.3389/fnume.2022.1032444. eCollection 2022.
4
F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis.F-FDG-PET/MR 成像用于监测大血管血管炎的疾病活动。
Nat Commun. 2024 Aug 25;15(1):7314. doi: 10.1038/s41467-024-51613-1.
5
Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.未来的核心脏肿瘤学故事——从预测到诊断和监测。
Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1129-1145. doi: 10.1093/ehjci/jead168.
6
Implant Imaging: Perspectives of Nuclear Imaging in Implant, Biomaterial, and Stem Cell Research.植入物成像：核成像在植入物、生物材料和干细胞研究中的应用前景
Bioengineering (Basel). 2023 Apr 25;10(5):521. doi: 10.3390/bioengineering10050521.
7
Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome.急性心肌梗死后早期患者的心肌成纤维细胞激活：与 MR 组织特征分析及随后的功能预后的整合。
J Nucl Med. 2022 Sep;63(9):1415-1423. doi: 10.2967/jnumed.121.263555. Epub 2022 Feb 24.
8
Large-vessel vasculitis.大血管血管炎
Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5.
9
Clinical perspectives for the use of total body PET/CT.全身PET/CT应用的临床视角
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1712-1718. doi: 10.1007/s00259-021-05293-4.
10
USPIO-Enhanced CMR of Myocardial Inflammation: What Are We Imaging?超顺磁性氧化铁增强磁共振成像评估心肌炎症：我们在成像什么？
JACC Cardiovasc Imaging. 2021 Feb;14(2):377-378. doi: 10.1016/j.jcmg.2020.12.022.
本文引用的文献
1
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.18F-氟代脱氧葡萄糖正电子发射断层扫描用于识别破裂和高风险的冠状动脉粥样硬化斑块：一项前瞻性临床试验。
Lancet. 2014 Feb 22;383(9918):705-13. doi: 10.1016/S0140-6736(13)61754-7. Epub 2013 Nov 11.
Zotero 插件